200 related articles for article (PubMed ID: 35834271)
21. miR-132-3p promotes the cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells by targeting SIRT1 via the NF-κB pathway.
Han S; Lin F; Ruan Y; Zhao S; Yuan R; Ning J; Jiang K; Xie J; Li H; Li C; Rao T; Yu W; Xia Y; Zhou X; Cheng F
Int Immunopharmacol; 2021 Oct; 99():108022. PubMed ID: 34339961
[TBL] [Abstract][Full Text] [Related]
22.
Zhang W; Hou J; Yan X; Leng J; Li R; Zhang J; Xing J; Chen C; Wang Z; Li W
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235825
[TBL] [Abstract][Full Text] [Related]
23. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
[TBL] [Abstract][Full Text] [Related]
24. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
25. Hypoxic preconditioning protects cardiomyocytes against hypoxia/reoxygenation-induced cell apoptosis via sphingosine kinase 2 and FAK/AKT pathway.
Zhang R; Li L; Yuan L; Zhao M
Exp Mol Pathol; 2016 Feb; 100(1):51-8. PubMed ID: 26621495
[TBL] [Abstract][Full Text] [Related]
26. Repurposing AZD5438 and Dabrafenib for Cisplatin-Induced AKI.
Pushpan CK; Kresock DF; Ingersoll MA; Lutze RD; Keirns DL; Hunter WJ; Bashir K; Teitz T
J Am Soc Nephrol; 2024 Jan; 35(1):22-40. PubMed ID: 37962623
[TBL] [Abstract][Full Text] [Related]
27. Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death.
Gao L; Liu MM; Zang HM; Ma QY; Yang Q; Jiang L; Ren GL; Li HD; Wu WF; Wang JN; Wei B; Liu XQ; Jiang C; Huang C; Li J; Meng XM
Lab Invest; 2018 Jul; 98(7):911-923. PubMed ID: 29581579
[TBL] [Abstract][Full Text] [Related]
28. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
[TBL] [Abstract][Full Text] [Related]
29. [Correlation analysis of inflammatory response and Klotho expression in renal tissue of mice with acute renal injury induced by cisplatin].
Wu C; Liu L; Xu W; Jian J; Zhang N; Wang X; Guo B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Aug; 35(8):702-706. PubMed ID: 31638567
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of hepatocyte nuclear factor 1β contributes to cisplatin nephrotoxicity via regulation of nf-κb pathway.
Zhang Y; Hao J; Du Z; Li P; Hu J; Ruan M; Li S; Ma Y; Lou Q
J Cell Mol Med; 2021 Mar; 25(6):2861-2871. PubMed ID: 33512774
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling.
Liu Y; Webb HK; Fukushima H; Micheli J; Markova S; Olson JL; Kroetz DL
J Pharmacol Exp Ther; 2012 Jun; 341(3):725-34. PubMed ID: 22414856
[TBL] [Abstract][Full Text] [Related]
32. Genetic deficiency of adiponectin protects against acute kidney injury.
Jin X; Chen J; Hu Z; Chan L; Wang Y
Kidney Int; 2013 Apr; 83(4):604-14. PubMed ID: 23302722
[TBL] [Abstract][Full Text] [Related]
33. LIGHT deficiency aggravates cisplatin-induced acute kidney injury by upregulating mitochondrial apoptosis.
Yang Y; Meng L; Wu S; Li Y; Zhong Y; Xu F; Zhou XC; Li GQ; Xu GL; Peng KF
Int Immunopharmacol; 2020 Dec; 89(Pt A):106999. PubMed ID: 33045563
[TBL] [Abstract][Full Text] [Related]
34. Genetic Knockout of Fatty Acid Amide Hydrolase Ameliorates Cisplatin-Induced Nephropathy in Mice.
Chen C; Wang W; Raymond M; Ahmadinejad F; Poklis JL; Em B; Gewirtz DA; Lichtman AH; Li N
Mol Pharmacol; 2023 Apr; 103(4):230-240. PubMed ID: 36702548
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8.
Guo C; Pei L; Xiao X; Wei Q; Chen JK; Ding HF; Huang S; Fan G; Shi H; Dong Z
Kidney Int; 2017 Nov; 92(5):1194-1205. PubMed ID: 28709638
[TBL] [Abstract][Full Text] [Related]
36. PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury.
Wang Y; Tang C; Cai J; Chen G; Zhang D; Zhang Z; Dong Z
Cell Death Dis; 2018 Nov; 9(11):1113. PubMed ID: 30385753
[TBL] [Abstract][Full Text] [Related]
37. Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury.
Oh CJ; Ha CM; Choi YK; Park S; Choe MS; Jeoung NH; Huh YH; Kim HJ; Kweon HS; Lee JM; Lee SJ; Jeon JH; Harris RA; Park KG; Lee IK
Kidney Int; 2017 Apr; 91(4):880-895. PubMed ID: 28040265
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
[TBL] [Abstract][Full Text] [Related]
39. Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway.
Wen L; Tao SH; Guo F; Li LZ; Yang HL; Liang Y; Zhang LD; Ma L; Fu P
Acta Pharmacol Sin; 2022 Aug; 43(8):2067-2080. PubMed ID: 34937916
[TBL] [Abstract][Full Text] [Related]
40. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2.
Yang Y; Liu S; Gao H; Wang P; Zhang Y; Zhang A; Jia Z; Huang S
Free Radic Biol Med; 2020 May; 152():821-837. PubMed ID: 32004633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
